| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -7.3e-05 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 7.7e-05 | 1 |